# Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study

> **NCT06568640** · NA · RECRUITING · sponsor: **Second Affiliated Hospital of Nanchang University** · enrollment: 20 (estimated)

## Conditions studied

- Essential Hypertension

## Interventions

- **PROCEDURE:** Superselective adrenal arterial embolization

## Key facts

- **NCT ID:** NCT06568640
- **Lead sponsor:** Second Affiliated Hospital of Nanchang University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-08-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 20 (ESTIMATED)
- **Last updated:** 2024-08-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06568640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06568640, "Superselective Adrenal Arterial Embolization for Refractory Hypertension: A Proof-of-Concept Study". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT06568640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*